Recent Updates
Recently added Catalysts
HCA Positive Sentiment

INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare reports SECOND quarter 2025 results RAISES 2025 Guidance Nashville, Tenn.

Friday, July 25, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: HCA Healthcare, Inc. announced its financial and operational results for the second quarter of 2025, highlighting growth in key metrics. The company also raised its guidance for the full year, suggesting optimism about future performance. These results reflect a positive trend compared to the same period in the previous year.
Price reaction · baseline $341.48 (2025-07-24 close) · hit after-hours · clean, no other HCA news in the window
day 0 close · peak
-2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • HCA Healthcare reported impressive second quarter results for 2025.
  • The company raised its guidance for 2025, indicating confidence in growth.
  • Key financial metrics show improvement compared to the previous year.

Full Press Release Details

FOR IMMEDIATE RELEASE
INVESTOR CONTACT: MEDIA CONTACT:
Frank Morgan Harlow Sumerford
615-344-2688 615-344-1851
HCA Healthcare reports SECOND quarter 2025 results
RAISES 2025 Guidance
Nashville, Tenn., July 25, 2025 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2025.
Key second quarter metrics (all percentage changes compare 2Q 2025 to 2Q 2024 unless otherwise noted):

Frequently Asked Questions

What financial results did HCA Healthcare announce?

HCA Healthcare revealed its second quarter financial results for 2025.

When did HCA Healthcare release its second quarter results?

HCA Healthcare published its second quarter results on July 25, 2025.

What does the recent report include?

The report includes key financial and operational metrics for Q2 2025.

Has HCA Healthcare adjusted its 2025 guidance?

Yes, HCA Healthcare has raised its guidance for 2025.

ShareAdd on Google
Tags: HCA Viatris Investor Conferences Healthcare HCA Healthcare Q2 2025 results financial guidance Nashville
Last updated: Jul 25, 2025

Biotech snapshot

Cash runway
$1415M liquidity · $0M/mo burn
Low dilution risk